Original Research

Published on 25 Jan 2022

Paradoxical Association Between Baseline Apolipoprotein B and Prognosis in Coronary Artery Disease: A 36,460 Chinese Cohort Study

in Lipids in Cardiovascular Disease

Huanqiang Li
Bo Wang
Ziling Mai
Sijia Yu
Ziyou Zhou
Hongyu Lu
Wenguang Lai
Qiang Li
Yongquan Yang
Jingru Deng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.822626

4,778 views
5 citations

Original Research

Published on 20 Jan 2022

Optimal Low-Density Lipoprotein Cholesterol Levels in Adults Without Diabetes Mellitus: A Nationwide Population-Based Study Including More Than 4 Million Individuals From South Korea

in Lipids in Cardiovascular Disease

Ji Hye Huh
Sang Wook Park
Tae-Hwa Go
Dae Ryong Kang
Sang-Hak Lee
Jang-Young Kim

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.812416

2,970 views
3 citations

Review

Published on 14 Jan 2022

Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk

in Lipids in Cardiovascular Disease

Loni Berkowitz
Fernanda Cabrera-Reyes
Cristian Salazar
Carol D. Ryff
Christopher Coe
Attilio Rigotti

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.785124

4,603 views
10 citations

Case Report

Published on 13 Jan 2022

Case Report: Next Generation Sequencing in Clinical Practice–A Real Tool for Ending the Protracted Diagnostic Odyssey

in Lipids in Cardiovascular Disease

Alena S. Limonova
Alexandra I. Ershova
Alexey N. Meshkov
Anna V. Kiseleva
Mikhail G. Divashuk
Marina V. Kurkina
Oxana M. Drapkina

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.778961

2,718 views
1 citation

Original Research

Published on 13 Jan 2022

Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients

in Lipids in Cardiovascular Disease

Younan Yao
Jin Liu
Bo Wang
Ziyou Zhou
Xiaozhao Lu
Zhidong Huang
Jingru Deng
Yongquan Yang
Ning Tan
Shiqun Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.817442

3,418 views
2 citations

Review

Published on 10 Jan 2022

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis

in Lipids in Cardiovascular Disease

Constanze Hoebinger
Dragana Rajcic
Tim Hendrikx

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.824481

5,592 views
21 citations

Original Research

Published on 20 Dec 2021

Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations

in Lipids in Cardiovascular Disease

Kongyong Cui
Hao-Yu Wang
Dong Yin
Chenggang Zhu
Weihua Song
Hongjian Wang
Lei Jia
Dong Zhang
Chenxi Song
Lei Feng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.807925

3,424 views
8 citations

Original Research

Published on 15 Dec 2021

Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome

in Lipids in Cardiovascular Disease

Xi Luo
Wang-Yu Cai
Xiao-Ke Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.790454

2,993 views
12 citations

Systematic Review

Published on 13 Dec 2021

Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis

in Lipids in Cardiovascular Disease

Jane J. Lee
Gerald Chi
Clara Fitzgerald
Syed Hassan A. Kazmi
Arzu Kalayci
Serge Korjian
Danielle Duffy
Alka Shaunik
Bronwyn Kingwell
Robert W. Yeh

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.774418

5,498 views
41 citations

Original Research

Published on 10 Dec 2021

Hematopoietic Cell-Specific SLC37A2 Deficiency Accelerates Atherosclerosis in LDL Receptor-Deficient Mice

in Lipids in Cardiovascular Disease

Qingxia Zhao
Zhan Wang
Allison K. Meyers
Jennifer Madenspacher
Manal Zabalawi
Qianyi Zhang
Elena Boudyguina
Fang-Chi Hsu
Charles E. McCall
Cristina M. Furdui

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.777098

3,709 views
2 citations

Original Research

Published on 06 Dec 2021

An Inhibitor of Grp94 Inhibits OxLDL-Induced Autophagy and Apoptosis in VECs and Stabilized Atherosclerotic Plaques

in Lipids in Cardiovascular Disease

Qun Wei
Hui Ren
Jun Zhang
Wen Yao
Baoxiang Zhao
Junying Miao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.757591

3,102 views
7 citations

Review

Published on 02 Dec 2021

Cerebrovascular Disease and Statins

in Lipids in Cardiovascular Disease

Luis M. Beltrán Romero
Antonio J. Vallejo-Vaz
Ovidio Muñiz Grijalvo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.778740

10,193 views
18 citations

Original Research

Published on 02 Dec 2021

The Increase in Paraoxonase 1 Is Associated With Decrease in Left Ventricular Volume in Kidney Transplant Recipients

in Lipids in Cardiovascular Disease

Philip W. Connelly
Andrew T. Yan
Michelle M. Nash
Rachel M. Wald
Charmaine Lok
Lakshman Gunaratnam
Anish Kirpalani
G. V. Ramesh Prasad

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.763389

1,883 views
2 citations

Review

Published on 29 Nov 2021

Statin Therapy in Very Old Patients: Lights and Shadows

in Lipids in Cardiovascular Disease

Lidia Cobos-Palacios
Jaime Sanz-Cánovas
Mónica Muñoz-Ubeda
María Dolores Lopez-Carmona
Luis Miguel Perez-Belmonte
Almudena Lopez-Sampalo
Ricardo Gomez-Huelgas
Maria Rosa Bernal-Lopez

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.779044

24,180 views
12 citations

Systematic Review

Published on 24 Nov 2021

Effect of Sodium Tanshinone IIA Sulfonate Injection on Blood Lipid in Patients With Coronary Heart Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

in Lipids in Cardiovascular Disease

Hufang Zhou
Ying Zhao
Wenhua Peng
Wenbo Han
Zichen Wang
Xiaoxia Ren
Dayang Wang
Guozhong Pan
Qian Lin
Xian Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.770746

3,617 views
10 citations

Review

Published on 24 Nov 2021

Statins in Non-alcoholic Steatohepatitis

in Lipids in Cardiovascular Disease

Jose D. Torres-Peña
Laura Martín-Piedra
Francisco Fuentes-Jiménez

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.777131

11,048 views
17 citations

Navigation group

Articles

Paradoxical Association Between Baseline Apolipoprotein B and Prognosis in Coronary Artery Disease: A 36,460 Chinese Cohort Study

Optimal Low-Density Lipoprotein Cholesterol Levels in Adults Without Diabetes Mellitus: A Nationwide Population-Based Study Including More Than 4 Million Individuals From South Korea

Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk

Case Report: Next Generation Sequencing in Clinical Practice–A Real Tool for Ending the Protracted Diagnostic Odyssey

Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis

Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations

Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome

Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis

Hematopoietic Cell-Specific SLC37A2 Deficiency Accelerates Atherosclerosis in LDL Receptor-Deficient Mice

An Inhibitor of Grp94 Inhibits OxLDL-Induced Autophagy and Apoptosis in VECs and Stabilized Atherosclerotic Plaques

Cerebrovascular Disease and Statins

The Increase in Paraoxonase 1 Is Associated With Decrease in Left Ventricular Volume in Kidney Transplant Recipients

Statin Therapy in Very Old Patients: Lights and Shadows

Effect of Sodium Tanshinone IIA Sulfonate Injection on Blood Lipid in Patients With Coronary Heart Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Statins in Non-alcoholic Steatohepatitis